Glofitamab (Anti-CD20 & CD3)
Product Specifications
CAS Number
2229047-91-8
Synonyms
RG6026, RO7082859
SKU
C00881-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Glofitamab is a T-cell–engaging bispecific antibody that targets CD3 and CD20, demonstrating significant antitumor activity and durable responses in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) . It works by binding to CD20 on B cells and CD3 on T cells, promoting T-cell-mediated lysis of malignant B cells. MW: 170.28 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC204692L4V 200 µL
Fibroblast activation protein, alpha (FAP) (NM_004460) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details